Research profile · Blends
Cartalax + BPC-157 + TB-500
Bioregulator and repair peptide blend
Available as: 10mg+5mg+5mg
Overview
A blend of the bioregulator tripeptide Cartalax (Ala-Glu-Asp) with BPC-157 and TB-500, supplied as single vials or 10-vial packs.
Mechanism
Combines Cartalax's proposed regulation of gene expression in cartilage and connective-tissue cells with BPC-157's angiogenic and nitric-oxide effects and the actin regulation and cell migration of thymosin β4.
Research highlights
- Cartalax: studied in cell-ageing models of connective tissue, mainly in Russian publications.
- BPC-157: accelerated healing of tendon, ligament, muscle, bone and gut lesions in rodent models.
- TB-500: thymosin β4 accelerated healing of skin wounds, corneal injuries and cardiac tissue in research models.
Compound data
- Components
- Cartalax 10 mg + BPC-157 5 mg + TB-500 5 mg
- Form
- Single vial or 10-vial pack